CN Patent

CN115245495B — 一种西格列汀二甲双胍片及其制备方法

Assigned to Jilin Huisheng Biopharmaceutical Co ltd · Expires 2022-12-23 · 3y expired

What this patent protects

本发明涉及一种西格列汀二甲双胍片及其制备方法，本发明提供的制备方法选择特定粒径的二甲双胍原料，并选择特定的辅料与原料药，配合特别配制的粘合剂溶液，制备成为药物颗粒，然后经过总混、压片及包衣等程序制备得到西格列汀二甲双胍片。利用本发明提供的制备方法制备得到的西格列汀二甲双胍片的溶出均匀，并且具有优异的稳定性。

USPTO Abstract

本发明涉及一种西格列汀二甲双胍片及其制备方法，本发明提供的制备方法选择特定粒径的二甲双胍原料，并选择特定的辅料与原料药，配合特别配制的粘合剂溶液，制备成为药物颗粒，然后经过总混、压片及包衣等程序制备得到西格列汀二甲双胍片。利用本发明提供的制备方法制备得到的西格列汀二甲双胍片的溶出均匀，并且具有优异的稳定性。

Drugs covered by this patent

Patent Metadata

Patent number
CN115245495B
Jurisdiction
CN
Classification
—
Expires
2022-12-23
Drug substance claim
No
Drug product claim
No
Assignee
Jilin Huisheng Biopharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.